Print
HVTN 080
Trial Details:
Phase:
I
Status:
Completed
Organizer developer:
VGX, HVTN
Start Date:
November 01, 2009
Product:
PENNVAX-B
Antigen:
Env, gag, pol B
Prime 1:
PENNVAX-B
Prime Class:
DNA
Boost 1:
Boost 1 class:
Boost 2:
Boost 2 Class:
Boost 3:
Boost 3 Class:
Adjuvant:
IL-12 DNA adjuvant
Country:
USA
Volunteers:
48
ClinicalTrials.gov Identifier:
NCT00991354
Link:
http://clinicaltrials.gov/ct2/show/NCT00991354?term=hvtn+080&rank=1